Chinese venture capital firm Shiyu Capital has led a RMB1.97 billion (US$278.5 million) Series A financing round in Mabwell Biotech, a Shanghai-based innovative biopharmaceutical company. Oriental Fortune Capital, Loyal Valley Innovation Capital, Haitong Innovation Capital Management, Founder H Fund, Haurong Rongde Asset Management, Huajin Capital, Sincere Capital, Winfast Holding and other investors also participated in […] Shiyu Capital Leads $278M Series A Round In Chinese Pharmaceutical Startup Mabwell comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.